Unitedhealth Group Inc (UNH) · Oct 13, 2026 · Earnings

UnitedHealth earnings beat as margins recover, membership shrinks

Beat — Adjusted EPS $4.69 vs roughly $4.15 consensus

UnitedHealth Group earnings beat third-quarter expectations and lifted its 2026 outlook, but Medicare Advantage and Optum Health membership remain under pressure.

UnitedHealth is in a recovery and repricing phase: it is shrinking Medicare Advantage and value-based-care exposure in weaker markets while rebuilding profitability through tighter pricing and operating discipline. Its prior outlook already implied a difficult membership reset and margin recovery, so this quarter matters mainly because the recovery is arriving faster than expected.

The quarter clearly beat the market’s earnings bar. Adjusted EPS was $4.69 versus published expectations around $4.15, while revenue was $112.7 billion versus roughly $112.5 billion expected. The operating improvement was substantial: earnings from operations rose to $6.6 billion from $4.3 billion a year earlier, even though revenue declined slightly.

MetricQ3 2026Comparison
Revenue$112.7B$113.2B in Q3 2025
Earnings from operations$6.6B$4.3B in Q3 2025
Adjusted EPS$4.69$2.92 in Q3 2025; ~$4.15 consensus
Medical care ratio88.4%89.9% in Q3 2025
Operating cost ratio12.8%13.5% in Q3 2025
Full-year adjusted EPS outlookAt least $20.50Previously $19.50-$20.00

The margin repair is the main business signal. The medical care ratio fell to 88.4% and the operating cost ratio to 12.8%, showing that pricing, benefit changes, cost controls and operational efficiencies are offsetting elevated healthcare utilization. However, $610 million of favorable prior-period reserve development helped the medical-cost result, so the quarter was not entirely a clean run-rate demonstration.

Management raised the outlook because the recovery is gaining traction. Full-year adjusted EPS is now expected to be at least $20.50, up from the prior $19.50-$20.00 range, while GAAP EPS is expected to be at least $19.50. That is more than a routine reaffirmation: it says the improved medical-cost and operating trends are carrying enough confidence into the fourth quarter to support a higher floor.

The improvement is uneven, with membership still being deliberately sacrificed. UnitedHealthcare’s operating earnings rose to $2.8 billion from $1.8 billion despite revenue falling to $86.3 billion. Medicare & Retirement revenue fell to $42.4 billion, and seniors served through Medicare Advantage-related programs have contracted by 935,000 since year-end 2025. The 2027 Stars result—at least 69% of members in plans rated four stars or better—was in line with expectations, so quality execution is holding up while scale is being reduced. 〔0〕

Optum Health is recovering operationally, not yet growing. Its operating earnings jumped to $735 million from $41 million and margin reached 3.2%, but revenue fell 10% to $22.9 billion because fewer value-based-care patients were served in markets where UnitedHealth lacked enough scale. That means the turnaround is currently being powered by exiting or resizing weak exposure and improving execution, rather than by broad-based patient growth.

Bottom line: This is a meaningful beat-and-raise that confirms UnitedHealth’s margin recovery is arriving ahead of the market’s near-term expectations. The catch is that the recovery still depends on disciplined retrenchment, with Medicare Advantage and Optum Health membership declining rather than expanding.

Original filing on SEC EDGAR

More Unitedhealth Group Inc news

UnitedHealth earnings beat as margins recover, membership shrinks | UNH Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.